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Background. The prevalence of acute kidney injury (AKI) reaches ~30% in neonates admitted to a tertiary level 
neonatal intensive care unit. Novel urinary biomarkers are useful for the prediction and diagnosis of AKI. The objective 
of this work was to determine the predictive and diagnostic value of urinary protein biomarkers for AKI in critically 
sick full-term newborns. 
Materials and methods. A prospective cohort study of 150 full-term neonates was performed. Group I included 55 
healthy newborns, group II – 50 critically ill newborns without AKI, group III – 45 critically ill newborns with AKI. 
Creatinine levels in serum (SCr), urinary concentration of total protein (UTPr), urinary albumin (UAlb), urinary im-
munoglobulin G (UIgG), urinary α1-microglobulin (Uα1-MG) and β2-microglobulin (Uβ2-MG) were measured on the 
3rd day of life. In case the data were available, 2×2 tables were constructed to derive sensitivity (Se), specifi city (Sp), 
positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (PLR), negative likelihood 
ratio (NLR) and cut-off level of urinary protein biomarkers. The area under the receiver operating characteristic (AU-
ROC) curve was used to deduce the diagnostic accuracies of them. 
Results. Considering AUROC values, the results of the conducted statistical analysis demonstrated that the 
biggest diagnostic value concerning AKI determination in critically ill term newborns was peculiar for the model 
with determination of UIgG level (AUROC 0.79; 95% СІ 0.69-0.88, р<0.001 with сut-off level ≥ 5.1 mg/L). Similar 
diagnostic value was found in the models with determination of Uα1-MG (AUROC 0.73; 95% СІ 0.64-0.84, р<0.05 
with сut-off level ≥ 42 mg/L) and UTPr (AUROC 0.73; 95% СІ 0.62-0.83, р<0.05 with сut-off level ≥ 186 mg/L). 
The model with determination of UAlb (AUROC 0.64; 95% СІ 0.53-0.76, р<0.05 with сut-off level ≥ 23.0 mg/L) pos-
sessed the least diagnostic value. The laboratory test with determination of Uβ2-MG level demonstrated the absence 
of diagnostic value concerning AKI determination in term newborns (AUROC 0.56; 95% СІ 0.5-0.68, р>0.05 with 
сut-off level ≥ 2.95 mg/L). 
Conclusions: 1. A comprehensive clinical-paraclinical examination should be performed for timely diagnostics of 
AKI in critically ill term newborns with determination of early markers of renal dysfunction including urinary protein 
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Introduction: The prevalence of acute kidney in-
jury (AKI) reaches ~30% in neonates admitted to a 
tertiary level neonatal intensive care unit [1]. In most 
studies, perinatal asphyxia, sepsis, respiratory distress 
syndrome, dehydration, congestive heart failure and 
nephrotoxic drugs are the most commonly associated 
conditions [2, 3]. The most common form of AKI in 
neonates is prerenal failure due to renal hypo-per-
fusion or ischemia. And newborn infants are vulner-
able to acute tubular necrosis or cortical necrosis [3].
Current identifi cation of AKI relies on acute eleva-
tion of serum creatinine (SCr), but SCr-based defi ni-
tions are hampered by numerous problems: most im-
portant, that SCr is a measure of function, not dam-
age. In neonates, SCr-based AKI defi nitions present 
additional challenges because SCr levels on postnatal 
day 1 refl ect maternal SCr, which declines over the 
next week or weeks depending on gestational age. In 
addition, acute changes in fl uid status, which occur 
during this time period, may have an important effect 
on SCr values [4]. 
Novel urinary biomarkers are useful for the 
prediction of AKI. Most promising are the urine 
markers neutrophil gelatinase-associated lipocalin, 
interleukin-18, kidney injury molecule and other. 
Each of these has shown considerable promise di-
agnosing AKI earlier than serum creatinine using 
disease controls [5]. Improving the ability to reli-
ably detect AKI would have important implications 
in the ability to care for critically ill neonates and 
will also improve the ability to perform clinical re-
search [4]. But many signifi cant questions, includ-
ing how to best defi ne, risk factors for, incidence of, 
early diagnosis, reference level of new markers, as-
sociation with other co-morbidities, and the short-
term and long-term outcomes after AKI remain un-
answered [1].
The objective of this work was to determine the 
predictive and diagnostic value of urinary protein bi-
omarkers for acute kidney injury (AKI) in critically 
sick full-term newborns.
Materials and methods. A prospective cohort 
study of 150 full-term neonates was performed. Group 
I included 55 healthy newborns, group II – 50 critical-
ly ill newborns without AKI, group III – 45 critically 
ill newborns with AKI. 
The critically sick neonates were grouped on the 
basis of the neonatal Therapeutic Intervention Scoring 
System (nTISS) and they had maximum nTISS score 
20 or higher [6]. The defi nition of AKI proposed by 
Jetton and Askenazi based on the Neonatal Acute Kid-
ney Injury (AKIN) classifi cation was used: increase of 
SCr by 0.3 mg/dl (25.6 μmol/l) or by 150-200% from 
the previous value and/or level of urine output less 
than 0.5 ml/kg/h for 6 to 12 hours [7]. The exclusion 
criteria of the study were birth weight ≤ 2500 g, early 
neonatal sepsis and major congenital anomalies of the 
kidneys and urinary tract. 
Urine and blood samples were collected on the 
3rd day and in cases of anuria/oliguria after restora-
tion of diuresis. Creatinine levels in serum (SCr) 
were measured using enzymatic method. The uri-
nary concentration of total protein (UTPr) was 
measured using protein dye-binding method, uri-
nary albumin (UAlb) – immunoturbidimetric meth-
od, immunoglobulin G (UIgG), α1-microglobulin 
(Uα1-MG) and β2-microglobulin (Uβ2-MG) – im-
munonephelometric method. All the tests kits were 
manufactured by the laboratory Gemeinschaftsla-
bor Cottbus (Germany).
The study was approved by the research ethics 
committee of Bukovinian State Medical University. 
Informed written consent was obtained from parents 
prior to enrollment of their babies into the study. All 
studies were conducted in compliance with the ba-
sic provisions of the Good Clinical Practice (1996), 
Council of Europe Convention on Human Rights 
and Biomedicine (1997), Helsinki Declaration of the 
World Medical Association on Ethical Principles for 
Medical Research (1964 - 2008).
Statistical analysis was performed by means of 
the software Statistica 7.0 (StatSoftInc., USA). The 
results of each group are expressed as mean (M) ± 
standard deviation (SD) for symmetric distributions. 
The normality of data distribution was tested us-
ing the Shapiro-Wilks test for sample size ≥ 30. To 
compare continuous variables, parametric tests (in-
dependent t test) were used. Fisher’s exact test was 
used to compare categorical variables. The differ-
ence of the parameters was considered to be statisti-
cally signifi cant with р<0.05. In case the data were 
available, 2×2 tables were constructed to derive 
sensitivity (Se), specifi city (Sp), positive predictive 
value (PPV), negative predictive value (NPV), posi-
tive likelihood ratio (PLR), negative likelihood ratio 
(NLR) and cut-off level of urinary protein biomark-
ers. The area under the receiver operating character-
istic (ROC) curve was used to deduce the diagnostic 
accuracies of them.
Results. No statistical differences exist in the ges-
tational age, body weight or gender signs of the three 
respective groups (Tab.1). 
biomarkers. 2. Considering the values of AUROC the level of diagnostic value of the presented biomarkers concerning 
detection of AKI was determined: UIgG > Uα1-MG, UTPr > UAlb with absent diagnostic value of Uβ2-MG. 3. None 
of the presented diagnostic models demonstrated high discriminating ability with high values of Se and Sp at the same 




Group I (n=55) Group II (n=50) Group III (n=45)
Gestational age, week, M±SD 39.1±1.15 38.9±1.34 39.0±1.39
Body mass, g, M±SD 3396.1±437.43 3374.9±521.4 3459.5±494.17
Sex (boys), n (%) 32 (58.2) 28 (56.0) 28 (62.2)
Sex (girls), n (%) 23 (41.8) 22 (44.0) 17 (37.8)
The healthy newborns did not have any problems 
in their early neonatal period. 
The critically ill neonates from group II had more 
serious disorders in the fi rst week of their life. 15 
(30.0%) newborns had signs of moderate asphyxia, 
3 (6.0%) had severe asphyxia, 8 (16.0%) had meco-
nium aspiration, 10 (20.0%) had moderate hypoxic-
ischemic encephalopathy (HIE), and 14 (28.0%) had 
severe HIE. Most newborns in this group had clini-
cal signs of multiple organ dysfunction syndrome 
(MODS): all of them had severe respiratory failure, 
12 (24.0%) had cardiovascular failure, 9 (18.0%) 
had hemorrhagic syndrome, 6 (12.0%) had seizures, 
5 (10.0%) had anemia, and 3 (6.05%) had necrotis-
ing enterocolitis.
In group III, 8 (17.8%) newborns had signs of 
moderate asphyxia, 12 (26.7%) had severe asphyxia 
(pII-III<0.05), 9 (20.0%) had meconium aspiration, 
6 (13.3%) had moderate HIE, and 10 (22.2%) had 
severe HIE. MODS occurred in all critically ill full-
term neonates with AKI. Severe respiratory failure 
was found in all 45 (100.0%) patients in group III, 
cardiovascular failure in 31 (68.9%; pII-III<0.05), 
hemorrhagic syndrome in 9 (20.0%), seizures in 9 
(20.0%), and anaemia in 8 (17.8%). 8 (17.8%) ne-
onates with AKI developed necrotising enterocolitis 
(pII-III<0.05). Certain association between AKI and 
severe asphyxia, cardiovascular failure, and necrotis-
ing enterocolitis was found.
The results of measurement of biochemical se-
rum and urine markers are presented in Tab. 2. The 
established marker of renal dysfunction SCr was sig-
nifi cantly higher in the groups of critically ill new-
borns with AKI as compared to the group of patients 
without AKI and healthy newborns. The critically ill 
newborns without AKI displayed signifi cantly higher 
values of SCr as compared to the healthy neonates. 
The results of the study did not demonstrate critical 
level of SCr in group III. It was due to detection of 
a common group of patients with AKI exceeding the 
criteria of SCr level, urine output or a combination 
of the two. 
The results of the examination of urinary pro-
tein biomarkers demonstrated that critically ill term 
newborns without AKI had moderate disorders of the 
renal tubular apparatus functioning with relatively 
preserved functions of glomerular barrier. It was evi-
denced by statistically much higher rates of urinary 
excretion of UAlb and Uα1-MG with relatively sta-
ble rates of UIgG and Uβ2-MG in infants of the ІІ 
group as compared to the infants from the І group. 
AKI formation in term children is accompanied by to-
tal disorders in the functioning of glomerular and tu-
bular renal apparatus. It was evidenced by statistically 
much higher rates of UTPr, UAlb, UIgG, Uα1-MG in 
children of the ІІІ group as compared to the children 
from the ІІ and І groups of the study. 
The glomerular basement membrane, vascular en-
dothelium of the capillaries and podocytes are com-
ponents of the glomerular fi ltration barrier which 
prevents leakage of protein. In a healthy neonatal kid-
ney, the proximal tubule function is often not mature 
enough to prevent leak of smaller proteins and there-
fore it is normal to see increased urinary protein in 
a neonates’ urine when compared to adult urine. The 
amount of physiologically normal protein excreted in 




Group I (n=55) Group II (n=50) Group III (n=45)
SCr, μmol/l, M±SD 41.6±8.49 54.1±11.78* 68.7±15.56*#
UTPr, mg/l, M±SD 165.4±64.75 142.5±35.09* 185.5±62.15#
UAlb, mg/l, M±SD 10.5±3.27 17.6±5.38* 21.3±8.63*#
UIgG, mg/l, M±SD 4.3±1.19 4.38±0.74 5.73±1.52*#
Uα1-MG, mg/l, M±SD 24.2±9.87 32.8±8.41* 42.7±14.74*#
Uβ2-MG, mg/l, M±SD 2.38±1.11 2.66±0.94 2.41±1.07
* − signifi cant difference from group I, p<0.05; # − signifi cant difference between groups II and III, p<0.05.
ROC analysis was conducted with calculation of appropriate operational characteristics to determine prognos-
tic and diagnostic value of the presented urinary protein biomarkers concerning neonatal AKI (Tab. 3). 
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Table 3. 
Results of ROC analysis of urinary protein biomarkers for neonatal AKI
UTPr UAlb UIgG Uα1-MG Uβ2-MG
Cut-off level, mg/l 186 23.0 5.1 42.0 2.95 
AUROC М 0.73 0.64 0.79 0.73 0.56
95% CI 0.62-0.83 0.53-0.76 0.69-0.88 0.64-0.84 0.5-0.68
р (AUC) 0.002 0.041 <0.001 0.001 0.23
Se,% М 48.9 46.7 71.1 62.2 71.1
95% CI 33.7-64.2 31.7-62.1 55.7-83.6 46.5-76.2 55.7-83.6
Sp, % М 90.0 82.0 82.0 86.0 41.8
95% CI 78.2-96.7 68.6-91.4 68.6-91.4 73.3-94.2 28.7-55.9
PPV, % М 81.5 70.0 78.1 80.0 50.0
95% CI 64.5-91.4 54.5-82.0 65.7-86.9 65.9-89.2 42.8-57.2
NPV, % М 66.2 63.1 75.9 71.7 63.9
95% CI 59.2-72.5 55.8-69.8 66.2-83.6 65.9-89.2 50.4-75.5
PLR М 4.89 2.59 3.95 4.44 1.22
95% CI 2.02-11.8 1.33-5.06 2.12-7.35 2.16-9.17 0.91-1.64
NLR М 0.57 0.65 0.35 0.44 0.69
95% CI 0.42-0.77 0.48-0.88 0.22-0.57 0.30-0.65 0.40-1.20
Discussion. The amount of urinary excreted proteins, 
especially those of low molecular weight proteinuria, is a 
result of glomerular fi ltration of proteins and their reab-
sorption in the proximal tubules [9]. Acute tubular necro-
sis is a common cause for AKI especially in the neonatal 
intensive care unit and as a consequence, proteinuria can 
be seen in the setting of this [8].
When making the diagnosis of AKI in critically 
ill children born in physiological term of gestation, 
the model with UTPr detection demonstrated good 
discriminating ability with сut-off level ≥ 186 mg/L 
(AUROC 0.73; 95% СІ 0.62-0.83, р<0.05), high Sp 
(90.0%; 95% СІ 78.2%-96.7%) and low Se (48.9%, 
95% СІ 33.7%-64.2%). It is indicative of the fact 
that examination of critically ill newborns will not 
fi nd AKI signs in 90.0% of cases in children with 
negative test result, but the diagnosis will be con-
fi rmed more than in 50.0% of cases with positive 
laboratory test. PPV, determining the probability of 
the disease available in a patient in case of a positive 
result of the test at the present moment, constituted 
81.5% (95% СІ 64.5%-91.4%); NPV, determining 
the probability of absence of the disease in case of a 
negative result of the test at the present moment was 
66.2% (95% СІ 59.2%-72.5%). Probability of a posi-
tive result in a newborn with AKI is approximately 5 
times as high compared to a negative result in a child 
without AKI, which is evidenced by PLR 4.89 (95% 
СІ 2.02-11.8).
Albumin is a 66 kDa, 585-amino acid, negatively 
charged globular protein found in plasma of mam-
mals. It is produced and excreted by the liver and is 
the most abundant protein in plasma. Serum albumin 
is multifunctional as it buffers pH; provides oncotic 
pressure; and is a carrier protein for a wide range of 
molecules, including amino acids, fatty acids, inor-
ganic ions, medications, and metabolites. Preventing 
or reducing urinary albumin excretion thus makes 
the kidney a key player in “protecting” the organism 
from excessive loss of albumin and its ligands. Albu-
min loss in urine has long been used as a marker of 
kidney injury, whether it originates from glomerular 
dysfunction, defective total protein reabsorption, or a 
combination [10].
When making the diagnosis of AKI in critically ill 
term newborns the model with UAlb determination 
demonstrated an average diagnostic value with сut-off 
level ≥ 23.0 mg/L (AUROC 0.64; 95% СІ 0.53-0.76, 
р<0.05). And this model was characterized by high Sp 
(82.0%; 95% СІ 68.6%-91.4%) and low Se (46.7%; 
95% СІ 31.7%-62.1%) with insuffi ciently high PPV 
(70.0%; 95% СІ 54.5%-82.0%) and NPV (63.1%; 
95% СІ 55.8%-69.8%) results. Probability of a posi-
tive result in newborns with AKI is approximately 2.6 
times as much compared to the probability of a nega-
tive result in children without AKI for the presented 
laboratory test, which is evidenced by PLR 2.59 (95% 
СІ 1.33-5.06).
Immunoglobulin G is a protein with high molec-
ular weight (150 kDa) which is produced by active 
lymphocytes, circulate in plasma as a component of 
the immune system. It does not penetrate through in-
tact glomerular membrane, and it’s not detected under 
physiological conditions in the urine of healthy indi-
viduals [11].
When making the diagnosis of severe renal dys-
function in term newborns the model with UIgG 
determination demonstrated good discriminating 
ability with сut-off level ≥ 5.1 mg/L (AUROC 0.79; 
95% СІ 0.69-0.88, р<0.001), high Sp (82.0%; 95% 
СІ 68.6%-91.4%) and moderate Se (71.0%; 95% СІ 
55.7%-83.6%), as well as moderate PPV (78.1%; 95% 
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СІ 65.7%-86.9%) and NPV (75.9%; 95% СІ 66.2%-
83.5%). Probability of a positive result in newborns 
with AKI is practically 4 times as high compared to a 
negative result in children without AKI for the given 
diagnostic pattern, which is evidenced by PLR 3.95 
(95% СІ 2.12-7.35).
α1-microglobulin is a glycosylated protein of mo-
lecular weight estimated to be between 26 kDa and 33 
kDa according to the type of measurement containing 
167 amino acids. α1-MG is synthesized in the liver, 
that is half of protein circulated is bound to immu-
noglobulin A complex. The free forms are fi ltrated by 
glomeruli and undergo reabsorption by proximal tu-
bular cells [12].
When making the diagnosis of AKI in term new-
borns with clinical signs of severe perinatal patholo-
gy the diagnostic model with determination of Uα1-
MG level demonstrated good discriminating ability 
with сut-off level ≥ 42 mg/L, which is evidenced by 
AUROC 0.73 (95% СІ 0.64-0.84, р<0.05). High Sp 
(86.0%; 95% СІ 73.3%-94.2%) with insuffi ciently 
high Se (62.2%; 95% СІ 46.5%-76.2%) are deter-
mined for this laboratory test. PPV, determining 
the probability of the disease available in a patient 
in case of a positive result of the test at the present 
moment, constituted 80.0% (95% СІ 65.9%-89.2%); 
NPV, determining the absence of the disease in case 
of a negative result of the test at the present moment 
was 71.7% (95% СІ 65.9%-89.2%). Probability of 
a positive result in critically ill newborns with AKI 
is approximately 4.5 times as high compared to the 
probability of a negative result in children without 
AKI, which is evidenced by PLR 4.44 (95% СІ 2.16-
9.17).
β2-microglobulin is a single-chain, low molecu-
lar weight (11,8 kDA) polypeptide and has similar 
structure to the CH3 domain of the immunoglobu-
lin molecule. β2-MG forms the invariant light chain 
portion of major histocompatibility complex class 
I molecules, which can be found on the membrane 
of all nucleated cells. β2-MG serves as a useful bi-
omarker to evaluate both glomerular and tubular 
function [13].
When making the diagnosis AKI in critically ill 
term newborns the test with Uβ2-MG determination 
was not diagnostically valuable, which was evidenced 
by the absence of statistically important AUROC lev-
el constituting 0.56 (95% СІ 0.5-0.68, р>0.05) with 
сut-off level of the index ≥ 2.95 mg/L. 
Therefore, considering AUROC values, the 
results of the conducted statistical analysis dem-
onstrated that the biggest diagnostic value con-
cerning AKI determination in critically ill term 
newborns was peculiar for the model with deter-
mination of UIgG level (AUROC 0.79; 95% СІ 
0.69-0.88, р<0.001 with сut-off level ≥ 5.1 mg/L). 
Similar diagnostic value was found in the models 
with determination of Uα1-MG (AUROC 0.73; 
95% СІ 0.64-0.84, р<0.05 with сut-off level ≥ 42 
mg/L) and UTPr (AUROC 0.73; 95% СІ 0.62-0.83, 
р<0.05 with сut-off level ≥ 186 mg/L). The model 
with determination of UAlb (AUROC 0.64; 95% СІ 
0.53-0.76, р<0.05 with сut-off level ≥ 23.0 mg/L) 
possessed the least diagnostic value. The laboratory 
test with determination of Uβ2-MG level demon-
strated the absence of diagnostic value concerning 
AKI determination in term newborns. 
Conclusions. 1. A comprehensive clinical-para-
clinical examination should be performed for timely 
diagnostics of AKI in critically ill term newborns with 
determination of early markers of renal dysfunction 
including urinary protein biomarkers (UTPr, UAlb, 
UIgG, Uα1-MG, Uβ2-MG). 2. Considering the values 
of AUROC the level of diagnostic value of the pre-
sented biomarkers concerning detection of AKI was 
determined: UIgG > Uα1-MG, UTPr > UAlb with 
absent diagnostic value of Uβ2-MG. 3. None of the 
presented diagnostic models demonstrated high dis-
criminating ability with high values of Se and Sp at 
the same time concerning detection of AKI in criti-
cally ill newborns. 
The perspectives for further studies are directed 
to the development of a comprehensive prognostic-
diagnostic mathematic model concerning determi-
nation of AKI in term newborns incl uding the most 
important risk factors, clinical signs, laboratory and 
instrumental methods of examination, investigation of 
their value and introducing into the practical work of 
medical establishments. 
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SUMMARY
Keywords: Androgen Insensitivity Syndrome. Androgen receptor, management, gonadal tumor, hormone 
replacement therapy, gonadectomy.
The goal In this article is discussed a clinical case of disorder of sex development (DSD) such us: Testicular femi-
nization in the context of contemporary literature.
Patient and Methods: A 15-year-old patient is admitted at Gynecology for primary amenorrhea. The clinical ex-
amination shows a female phenotype: the breasts are normally developed, but there few hair in the groins and axillary 
areas, the urinary meatus is normally inserted, and the vulva is unpigmented. The gynecological exam reveals that the 
hymen is present, the vagina short, while the uterus is absent. The karyotype was mapped in order to differentiate the 
androgen insensitivity syndrome from other genetic abnormalities. The testes were removed in order to avoid the ma-
lignant risk. We performed gonadectomy. 
Results: Surgically, the patient had a simple evolution. Mentally, the patient kept thinking she was a woman, so the 
decision of telling her the truth was left to the parents. 
Conclusions: Testicular feminization is a rare disease that must be diagnosed and treated through close work 
between gynecologists, endocrinologists, geneticians, urologists, and psychiatrists. Bilateral gonadectomy is the best 
procedure to avoid their malignant transformation.
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